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Abstract
Pathogenic bacteria secrete pore-forming toxins that permeabilize the plasma membrane of host cells. Nucleated cells
possess protective mechanisms that repair toxin-damaged plasmalemma. Currently two putative repair scenarios are
debated: either the isolation of the damaged membrane regions and their subsequent expulsion as microvesicles
(shedding) or lysosome-dependent repair might allow the cell to rid itself of its toxic cargo and prevent lysis. Here we
provide evidence that both mechanisms operate in tandem but fulfill diverse cellular needs. The prevalence of the repair
strategy varies between cell types and is guided by the severity and the localization of the initial toxin-induced damage, by
the morphology of a cell and, most important, by the incidence of the secondary mechanical damage. The surgically precise
action of microvesicle shedding is best suited for the instant elimination of individual toxin pores, whereas lysosomal repair
is indispensable for mending of self-inflicted mechanical injuries following initial plasmalemmal permeabilization by
bacterial toxins. Our study provides new insights into the functioning of non-immune cellular defenses against bacterial
pathogens.
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Introduction
Bacteria secrete toxins which form trans-membrane pores in the
plasmalemma of host cells [1,2]. The formation of the pores results
in plasmalemmal permeabilization followed by an influx of
extracellular and an efflux of intracellular components eventually
leading to cell lysis. Since the efflux of intracellular components,
which include lytic enzymes, can be detrimental to the surround-
ing non-injured cells and can also lead to the uncontrolled
activation of immune responses, cell lysis must be prevented by
any means. In nucleated mammalian cells this is achieved by the
process of plasmalemmal repair [3,4,5,6].
It is believed that the isolation of the damaged membrane
regions and their subsequent extracellular release as microvesicles
or intracellular internalization by lysosome-plasmalemmal fusion
and endocytosis allows the cell to rid itself of toxic cargo and re-
establish its homeostasis [7,8,9,10,11].
Lysosomal repair is instrumental in the resealing of mechani-
cally-induced plasmalemmal lesions where lysosomes provide
membrane material, which is required for the resealing of
mechanically-damaged plasmalemma [6,8]. This mode of repair
might also be involved in the repair of trans-membrane pores
formed by the bacterial toxin, streptolysin O (SLO). A currently
discussed scenario implies that Ca2+-dependent fusion between
lysosomes and the SLO-damaged plasmalemma leads to the
exposure of the sphingomyelin-rich outer leaflet of the plasma-
lemmal lipid bilayer to the lysosomal acid sphingomyelinase [11];
the ensuing generation of ceramide platforms causes pore-
containing plasmalemmal invaginations, which are subsequently
endocytosed [11,12].
The second repair scenario - microvesicle shedding - is
instrumental in the protection of neutrophils and endothelial cells
from the trans-membrane pores formed by the membrane attack
complex (MAC) of complement [13,14,15,16]. Recently, we have
shown that plasma membrane repair in cells, which were exposed
to SLO, was accomplished by the shedding of toxin-bearing
microvesicles [7,10]. The isolation and physical removal of the
toxin is triggered by the pore-induced rise in [Ca2+]i and is effected
by annexins; proteins which bind to phospholipids in a Ca2+-
dependent manner, displaying membrane aggregating and fuso-
genic properties [3,17].
The two modes of plasmalemmal repair differ in almost all
aspects but they are not mutually exclusive: in human neutrophils,
the MAC is removed both by endocytosis and microvesicle
shedding [16,18]. Whereas the shedding of the MAC predomi-
nates in neutrophils [16], endocytosis seems to be the primary
route of MAC elimination in Ehrlich ascites tumor cells [19].
Thus, both the endocytic and the shedding route may simulta-
neously contribute to the removal of the pore-forming toxins; their
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relative contribution might differ between cell types or even within
a particular cell type [16,18].
Studies, which directly compared the contribution of the two
mechanisms to the plasmalemmal repair of SLO pores, yielded
inconsistent results. Whereas one study showed that microvesicle
release but not lysosomal repair was responsible for the elimination
of SLO pores in CHO and HeLa cells [9]; a second investigation,
conducted on normal rat kidney (NRK), HeLa and HEK 293 cells
came to the opposite conclusion [8].
The present study explores whether the extent and localization
of the injury as well as the intrinsic features of a perforated cell
might define a preferential route of plasmalemmal repair.
Materials and Methods
Cell Culture and Transfections
Human embryonic kidney cells (HEK 293) were maintained as
previously described [12]. Human neuroblastoma (SH-SY5Y) cells
were maintained in modified Eagle’s medium supplemented with
10% fetal bovine serum and 1% penicillin and streptomycin. The
coding sequence of annexin A1 was cloned into the Living Colours
Fluorescent protein vectors (Clontech, Mountain View, USA)
following the PCR amplification from human bladder smooth
muscle cDNA [20]. YFP (yellow-fluorescent protein), CFP (cyan-
fluorescent protein), annexin A1-YFP or annexin A1-CFP were
transiently expressed in target cells [20].
Cell Lysis
Cell lysis was assessed by monitoring the irreversible elevation of
intracellular [Ca2+] above 20 mM, using the permanent translo-
cation of the calcium-sensitive protein annexin A1 from the
cytoplasm to the plasma membrane as a read-out [21]. Annexin
A1-transfected cells seeded on glass coverslips were mounted in a
perfusion chamber at 25uC in Tyrode’s buffer (140 mM NaCl,
5 mM KCl, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES;
pH=7.4) containing 2.5 mM CaCl2. At time-point = 0, the cells
were challenged with 100 ng/ml (if not stated otherwise) SLO
from Streptococcus pyogenes pre-activated with 20 mM DTT. When
indicated, the cells were pre-incubated with either Jasplakinolide
(Sigma-Aldrich; 100 nM, 60 min, 37uC), or Latrunculin A (Sigma-
Aldrich; 5 mM, 60 min, 37uC), or Calpeptin (Merck-Calbiochem;
60 mM, 30 min, 37uC), or Vacuolin-1 (Sigma-Aldrich; 20 mM,
3 h, 37uC), or Y-27632 (Sigma-Aldrich; 50 mM, 3 h, 37uC).
Translocation of annexin A1 was recorded in an Axiovert 200 M
microscope with a laser scanning module LSM 510 META (Zeiss,
Germany) using a663 oil immersion lens [7]. The images were
analysed using the ‘‘Physiology evaluation’’ software package
(Zeiss, Germany).
Annexin A1-positive microvesicles that were released in
individual experiments were counted manually (every 5th frame)
in the recorded videos (70 frames = 434s) and are expressed as
total number of microvesicles/total number of cells in each
individual experiment.
Fluorescence-activated Cell Sorting (FACS) and Western
Blot Analysis
Confluent HEK 293 cells transfected with annexin A1-YFP
were used for FACS analysis. Confluent non-transfected HEK 293
cells were used for Western Blotting. 16107 cells were used per
experiment. To generate microvesicles, cells were washed 3 times
with Tyrode’s buffer containing 2.5 mM CaCl2 and challenged for
20 min with SLO (100 ng/ml) pre-activated with 20 mM DTT.
When indicated, the cells were pre-incubated with either
Jasplakinolide (Sigma-Aldrich; 100 nM, 60 min, 37uC), or La-
trunculin A (Sigma-Aldrich; 5 mM, 60 min, 37uC), or Calpeptin
(Merck-Calbiochem; 60 mM, 30 min, 37uC), or Vacuolin-1
(Sigma-Aldrich; 20 mM, 3 h, 37uC). The microvesicle-containing
medium was collected, centrifuged first for 10 min at 1,500 g and
then for 30 min at 130,000 g. The pellet containing microvesicles
was resuspended in 2.5 mM CaCl2 Tyrode’s buffer and analysed
by FACS (SORP LSRII, Becton Dickinson, NJ USA). The Flowjo
program suite, version 9.2, was used for data analysis. For Western
Blotting analysis the pellet containing microvesicles was resus-
pended in 20 ml loading buffer. Primary anti-annexin A1 antibody
(Hybridoma EH17A) was from DSHB, University of Iowa.
Secondary HRP-conjugated antibody was from GE Healthcare,
UK.
b-Hexosaminidase Assay
Cells were grown to 70% confluence. SLO in Tyrode’s buffer
containing 2.5 mM Ca2+ was added for 15 min and culture
supernatants were collected immediately thereafter. Cells lysed by
sonication were used to estimate total cellular b-hexosaminidase
(100%). Released b-hexosaminidase was measured in culture
supernatants as described [22,23]. Fluorescence was measured at
365 nm (ex)/450 nm (em) using a Gemini EM Fluorescence
microplate reader.
Results
The Dynamics of the Subcortical Actin Cytoskeleton
Affect the Release of Microvesicles
Recently we have shown that plasmalemmal repair in SLO-
damaged HEK 293 cells is accomplished by the expulsion of
annexin- and toxin-bearing microvesicles [7,10]. Shedding of
annexin A1-rich microvesicles by repaired HEK 293 cells that
were treated with SLO/DTT is documented in Figure 1 and
Video S1, whereas Video S2 shows that treatment with DTT
alone did not induce microvesicle release.
Membrane tension, generated by the subcortical actin cytoskel-
eton, is a major factor that defines the rate of plasmalemmal
resealing [6]. Thus, we investigated whether the protection against
plasmalemmal injury brought about by the destabilization of the
actin cytoskeleton [8,24,25] can be attributed to enhanced
microvesicle release by SLO-damaged cells. Since significant
differences in microvesicle counts were attributed to minor
changes in experimental protocols in a number of studies (for
critical assessment of the methodological approaches, currently
Figure 1. Plasmalemmal repair in SLO-damaged cells is
accomplished by the expulsion of microvesicles. Shedding of
annexin A1-rich microvesicles by SLO-treated, annexin A1-YFP-express-
ing HEK 293 cells was recorded by laser-scanning confocal microscopy.
Magnification bar = 5 mm.
doi:10.1371/journal.pone.0089743.g001
Modes of Plasmalemmal Repair
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used in microvesicle research, please see: [26,27,28]), in the
present study, the amount of microvesicles, released under any
experimental condition (specific treatment+SLO), were directly
compared to the levels of microvesicles, released under the
condition of SLO-alone treatment; in each individual experiment
both protocols were always processed in parallel. Furthermore, to
minimize an inevitable contribution of artifacts in the evaluation of
our data, two independent approaches were used to analyze
microvesicle release.
Latrunculin A was used to destabilize the actin cytoskeleton
[29]. FACS analysis of microvesicle contents in the supernatants of
SLO-damaged cells revealed enhanced microvesicle shedding by
cells treated with latrunculin A (Fig. 2A). In accordance with
previous studies [8], destabilization of the actin cortex protected
HEK 293 cells from SLO induced cell death (Fig. 2B). In a
reciprocal experiment, HEK 293 cells were treated with
jasplakinolide to stabilize the actin cytoskeleton [30]. FACS
analysis of culture supernatants demonstrated a significantly lower
number of microvesicles released by the jasplakinolide/SLO-
treated cells compared to the SLO-treated cells (Fig. 2C). The
reduction in microvesicle shedding by jasplakinolide-treated cells
was accompanied by an increase in their lysis (Fig. 2D). In vivo, the
destabilization of the cortical actin cytoskeleton, which is required
for a successful repair of plasmalemmal lesions, is achieved by
calpains, a family of non-lysosomal Ca2+-dependent proteases
[31]. Calpeptin, a cell-permeable inhibitor of calpain [13,32,33],
reduced microvesicle shedding by SLO-damaged cells (Fig. 2E).
Consequently, SLO induced an increased rate of lysis in calpeptin-
treated cells (Fig. 2F). Neither cell lysis nor microvesicle shedding
was observed in control experiments in which cells were incubated
with DTT in the absence of SLO.
These findings were further validated in an independent
experiment. As documented in Figure 1A and Videos S1 and
S2, annexin A1 is exclusively released by shedding HEK 293 cells.
Therefore, the amounts of annexin A1 released by SLO-treated
cells were analyzed by Western Blotting in culture supernatants of
cells pre-treated with either latrunculin or jasplakinolide (Fig. 2G).
Destabilization of actin cytoskeleton by latrunculin increased
shedding of annexin A1 by SLO-damaged cells, whereas the
stabilization of the actin cytoskeleton reduced its amounts in the
culture medium below the detection limit of the method. No
shedding of annexin A1 was observed in cells treated with either
latrunculin alone or DTT alone (control).
Since destabilization of the cortical cytoskeleton also facilitates
lysosomal repair [8], it appears that both lysosomal repair and
microvesicle shedding are similarly affected by the flexibility of the
plasmalemmal lipid bilayer, which itself critically depends on the
remodeling of the underlying actin cytoskeleton. Also, the two
mechanisms are triggered by a pore-induced elevation in [Ca2+]i
[8,10]. These similarities make it even more important to
comprehend the specific features that guide a damaged cell in its
choice of a suitable repair strategy.
Repair of Limited Plasmalemmal Damage by Pinpoint
Microvesicle Shedding
Plasma membrane perforation by a toxin pore manifests itself in
the elevation of [Ca2+]i. As a result, the Ca
2+-dependent binding to
charged phospholipids drives the translocation of annexins from
the cytoplasm to the plasmalemma [3,7,10]. After pore formation,
the damaged membrane is quarantined by the annexins [3,10]
within compact plasmalemmal spots or within thin outward
protrusions and eventually shed into the extracellular milieu (Fig. 3,
Videos S1, S3, S4). Since the binding of annexins to the plasma
membrane occurs exclusively at elevated [Ca2+]i [3,17,20], the
Figure 2. Destabilization of the cortical cytoskeleton enhances
microvesicle release by SLO-damaged cells and potentiates
their survival. (A) Enhanced release of microvesicles by SLO-damaged
cells, which were treated with latrunculin A. (B) Latrunculin A protects
HEK 293 cells from SLO-induced cell lysis. (C) Diminished release of
microvesicles by SLO-damaged cells which were treated with jasplaki-
nolide. (D) Treatment with jasplakinolide results in increased cell lysis.
(E) Calpeptin reduces microvesicle release by SLO-damaged cells. (F)
SLO induces an increased rate of lysis in calpeptin-treated cells. **p,
0.001, *p,0.01. (G) Amounts of annexin A1 shed within microvesicles
were analyzed by Western Blotting in culture supernatants of SLO-
treated cells pre-treated with either latrunculin (Latr/SLO), jasplakinolide
(Jasp/SLO), cells treated with latrunculin without SLO treatment (Latr) or
cells treated with DTT only (Contr). **p,0.001.
doi:10.1371/journal.pone.0089743.g002
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Figure 3. Pinpoint shedding of microvesicles. Two HEK 293 and two SH-SY5Y cells transfected with annexin A1-YFP are shown. SLO-pores are
quarantined within compact plasmalemmal regions or within thin outward protrusions (arrows). An asterisk denotes the nucleus of a lysed cell.
Magnification bars = 5 mm.
doi:10.1371/journal.pone.0089743.g003
Modes of Plasmalemmal Repair
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pinpoint accumulation of annexin A1 at the damaged plasma-
lemma reveals that the pore-induced Ca2+ entry, which could
distort the otherwise tightly regulated Ca2+ homeostasis, remains
spatially confined.
Thus, annexin-mediated microvesicle shedding seems to be
optimal for the early repair of individual toxin pores allowing the
survival of damaged cells with minimal detrimental consequences.
The Plasmalemmal Repair of Toxin Pores Occurs in
Lysosome-free Intracellular Compartments
The lysosomal-fusion mode of plasmalemmal repair is restricted
to the cell body where lysosomes are localized, and thus is not
likely to happen at stable cellular protrusions such as axons or
dendrites which are usually free of intracellular organelles [34].
Such protrusions, which are located at the body’s periphery, are
most likely the very first cellular components to encounter
bacterial toxins. Figure 4A (Video S5) demonstrates that the
SLO-pores can be successfully eliminated from the plasmalemma
of the elongated, thin neurites of SH-SY5Y neuroblastoma cells.
The permeabilization manifests itself in the translocation of
annexin A1 within the neurite (Fig.4A, time= 1078 s). The
translocation of the annexin follows the propagation of the pore-
induced Ca2+-wave, which ceases before reaching the cell body,
whereupon annexin returns to the cytoplasm of the neurite
(Fig.4A, time= 1095 s, Video S5). Since the annexins can relocate
to the cytoplasm only after the toxin pores have been eliminated
and [Ca2+]i homeostasis has been re-established, the back-
translocation of the annexin marks the successful elimination of
the SLO-pores. Figure 4B documents plasmalemmal repair
occurring in a protrusion of a HEK 293 cell.
The intracellular trafficking of bulky lysosomes is expected to be
relatively slow. Thus, it is unlikely that a sufficient number of
lysosomes will be locally available for the plasmalemmal repair in
cells which undergo a continuous rearrangement of their shape.
Blebs are cytoplasmic spherical protrusions, sprouted by cells
during stressful conditions, which are connected to the cell body by
a thin neck, but which are free of intracellular organelles [35]. A
pore within a bleb manifests itself in the elevation of intra-bleb
[Ca2+]i followed by plasmalemmal translocation of annexin A1
within the perforated bleb (Fig. 5). Back-translocation of annexin
A1 into the cytoplasm reveals the successful elimination of the
SLO-pores from the plasmalemma of lysosome-free blebs (Fig.5;
Video S6). In the experiments described here, the pore-induced
[Ca2+]i elevation within the cell body remains low (annexin
remains in the cytoplasm). Thus, SLO-pores occurring within the
lysosome-free blebs can successfully be eliminated even before the
danger signal ([Ca2+]i-elevation) reaches the cell body.
Collectively, these results demonstrate that plasmalemmal
repair occurs in regions of the cell in which lysosomes are not
available. It is effected, most likely, via annexin-driven microves-
icle shedding since the carriers for this type of repair are
cytoplasmic proteins, which are expressed throughout the cell
including its cytoplasmic protrusions, and can also rapidly diffuse
into newly formed cellular compartments.
Extensive Toxin-induced Damage is Accompanied by
Self-inflicted Mechanical Damage
Extensive formation of toxin-pores does not only induce a
localized elevation of [Ca2+]i, which is needed to trigger
plasmalemmal repair, but can also push the global [Ca2+]i above
the threshold, required for a prolonged activation of cellular
contractile elements. The following uncontrolled contraction can
lead to substantial mechanical damage of the plasmalemma.
Figure 6A (Video S7) shows a toxin-perforated SH-SY5Y cell. The
toxin-induced Ca2+-elevation leads to a contraction of the cell’s
protrusion, which is tightly attached to the substratum. As a result,
the protrusion is wrenched apart by the mechanical forces. The
remains of the protrusion’s plasmalemma, which remains attached
to the substratum, are highlighted by bound annexin A1 (Fig. 6A,
Video S7). The global translocation of the annexin within the cell
Figure 4. The plasmalemmal repair of SLO pores occurs in
lysosome-free cellular protrusions. (A,B) SLO-induced plasmalem-
mal translocation/cytoplasmic back-translocation of annexin A1-YFP
marks the successful elimination of the SLO-pores in (A) a neurite of a
SH-SY5Y cell or in (B) a cytoplasmic protrusion of a HEK 293 cell. Arrows
denote the plasmalemmal translocation of annexin A1 (plasmalemmal
permeabilization). Magnified images of the squared region are shown in
(A). Magnification bars = 5 mm.
doi:10.1371/journal.pone.0089743.g004
Figure 5. The plasmalemmal repair of SLO pores occurs in
lysosome-free blebs. SLO-induced plasmalemmal translocation/
cytoplasmic back-translocation of annexin A1-YFP marks the successful
elimination of the SLO-pores in blebs of HEK 293 cells. Arrows denote
the plasmalemmal translocation of annexin A1 (plasmalemmal permea-
bilization). Magnification bars = 5 mm.
doi:10.1371/journal.pone.0089743.g005
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body and its nucleus manifests cell lysis. However, even such a
massive, self-inflicted mechanical damage of the plasmalemma can
be repaired. Figure 6B (Video S8) shows two HEK 293 cells which
are connected by long cytoplasmic protrusions. An initial
perforation occurring within a protrusion leads to a local
translocation of annexin A1 followed by contraction and rupture
of the protrusion of the lower cell. Its distal part remains attached
to the protrusion of the upper cell whereas the rest of the
protrusion is ripped apart by the strength of the contraction.
However, the plasmalemma at the base of the protrusion is able to
reform (Fig. 6B, arrow) and the cytoplasmic localization of
annexin A1 within the cell body is the evidence of successful
resealing of the plasmalemma (Fig. 6B). Likewise, the mechanical
lesions occurring in a SLO-perforated SH-SY5Y cell are efficiently
repaired (Fig. 6C; Video S9).
Inhibition of Myosin-driven Contraction does not
Increase Survival of Toxin-damaged SH-SY5Y Cells or HEK
293 Cells
Since an initial perforation of the plasmalemma by pore-
forming toxins can lead to massive secondary mechanical damage,
inflicted by the activated contractile machinery, we next probed
whether lysis of toxin-perforated cells might be prevented by
inhibiting myosin contraction with Y-27632 [36,37].
HEK 293 cells retain their bulky geometry when grown on glass
and do not form extensive adherence contacts with the substratum
at the cellular periphery (Fig. 7A). Since in HEK 293 cells the
contraction-induced damage events are relatively rare (Video S10)
and occur mostly in protrusions of adjacent cells which are linked
with each other (Fig. 6B), the inhibition of myosin contraction did
not lead to increased survival of these cells (Fig. 7B).
In contrast, SH-SY5Y cells spread on glass coverslips by
sprouting multiple protrusions, which adhere vividly to the support
(Fig.7A) and are prone to secondary mechanical injury when they
contract (Video S11). Most surprisingly, the inhibition of myosin
contraction also did not protect these cells from SLO-induced lysis
(Fig. 7B). Thus, mechanical damage was not the defining factor in
the lysis of SLO-perforated SH-SY5Y cells, most likely, because
such injuries were efficiently repaired.
Lysosomal Fusion is Essential for the Resealing of SH-
SY5Y Cells but not that of HEK 293 Cells
Annexins seem to be instrumental in quarantining mechanical
injuries (Fig. 6B,C, asterisks). However, since the resealing of
extended mechanical lesions requires a deposition of additional
membranous material [6], the pinpoint repair action of the
annexin-driven microvesicle release is not compatible with this
mode of repair. Instead, a lysosomal patch is much better suited
for the repair of such extensive lesions [6].
Correspondingly, lysosomal fusion accompanied by the release
of lysosomal b-hexosaminidase [22,23] was more prominent in
SLO-treated SH-SY5Y cells compared to HEK 293 cells (Fig. 7C).
Vacuolin-1, which blocks the Ca2+-dependent exocytosis of
lysosomes and thus prevents their fusion with the plasma
membrane [22,38], did not increase the SLO-induced lysis of
HEK 293 cells (Fig. 7D). In contrast, vacuolin-1 treatment
significantly enhanced the SLO-induced lysis of SH-SY5Y cells
(Fig. 7D). Thus, whereas myosin contraction and the concomitant
mechanical injuries themselves did not increase the rate of SLO-
induced SH-SY5Y cell lysis, the inhibition of repair mechanisms
that are responsible for the elimination of such injuries did.
Microvesicle Shedding and Lysosomal Repair
Complement each other during Plasmalemmal Repair in
SH-SY5Y Cells
Microvesicle shedding and repair of self-inflicted mechanical
lesions were observed in toxin-damaged HEK 293 and SH-SY5Y
cells. As discussed above, the self-inflicted mechanical damage was
only a minor occurrence in HEK 293 cells. Correspondingly, the
inhibition of lysosomal repair did not significantly affect the overall
outcome of plasmalemmal repair (Fig.7). Thus microvesicle
shedding was largely responsible for the repair of the toxin-
damaged plasmalemma in these cells. In contrast, the self-inflicted
mechanical damage was more frequent in SH-SY5Y cells
contributing significantly to the overall outcome of plasmalemmal
repair (Fig.7).
Our data suggest that self-inflicted mechanical damage, which
requires lysosomal repair, might occur preferentially in heavily-
damaged SH-SY5Y cells that initially failed to eliminate SLO-
pores by microvesicle shedding. To determine the relative
contribution of microvesicle shedding and lysosomal repair to
total plasmalemmal repair we evaluated the contribution of either
repair mechanism in individual experiments in which SH-SY5Y
cells a) repaired efficiently (lysis in any individual experiment was
below 20%) or b) suffered from extensive plasmalemmal damage
(lysis in any individual experiment was above 40%) (Fig.8A).
Figure 8B shows that during efficient repair (low damage),
significantly more microvesicles were shed by individual cells
compared to the experiments in which cells failed to repair
efficiently (high damage). Correspondingly, microvesicle shedding
was the predominant repair mechanism in the efficiently repaired
cells since only 961.5% of the cells suffered from secondary, self-
inflicted mechanical damage at these conditions (Fig. 8C). In
contrast, in the experiments in which cells failed to repair
efficiently, 4464.7% were damaged mechanically (Fig. 8C). No
significant difference between the two conditions was observed in
the repair of cells that suffered from the self-inflicted mechanical
damage (Fig. 8D). Whereas at the low damage conditions 4 out of
7 mechanically-damaged cells were able to repair (66.6616.6%),
15 out of 29 mechanically damaged cells repaired at the high
damage conditions (52.365.4%) suggesting that once the plasma-
lemmal damage was acute enough to induce self-inflicted
mechanical damage, the repair of individual mechanically
damaged cells was effected with the same efficiency by the same
mechanism (lysosomal repair). Thus, the difference in total
plasmalemmal repair observed between the two experimental
conditions (Fig, 8A) was largely defined by the efficiency of the
initial plasmalemmal repair effected by microvesicle shedding.
Overall, lysosomal repair was instrumental in 6.460.65% of cells
that repaired at low-damage conditions and in 4664.8% of cells
that repaired at the conditions of high damage (Fig, 8E).
Discussion
We show that both microvesicle shedding and lysosomal repair
are instrumental in the restoration of membrane barrier function
following plasmalemmal permeabilization by bacterial pore-
forming toxins.
Molecular mechanisms that govern lysosomal repair are well
characterized especially during repair of mechanical injuries
[4,5,6], whereas those effecting microvesicle shedding are not yet
established in detail. In particular, the mechanisms responsible for
the formation of the initial membrane evaginations, which are
required for the outward vesiculation and the processes that
govern the pinch-off of toxin-bearing microparticles are not well
characterized. It is conceivable that the initial outward curvature is
Modes of Plasmalemmal Repair
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brought about by the lipolytic processing of plasmalemmal
constituents [39], whereas the fusogenic activity of the annexins
might be responsible for the microparticle release [3].
Here we provide evidence that additional supportive or
alternative mechanisms might be at play. Our present results call
attention to the formation of thin outward protrusions during the
process of the elimination of individual SLO-pores by microvesicle
shedding, which resemble tunneling nanotubes,- membrane
nanostructures that are formed by a variety of cells under stress
conditions [40,41,42]. Nanotubes can also dilate into spherical
structures, similar to those described in the present report, that
may pinch off from- or remain attached to a mother cell [43].
Serving, presumably, as the means of direct cell-to-cell commu-
nication, the nanotubes have a diameter of 180–380 nm, are not
tethered to the substratum and might form direct seamless contacts
with the neighboring cells [41]. Whereas the stability of membrane
nanotubes in vivo is reinforced by an actin cytoskeleton, their
formation is governed exclusively by the thermodynamic proper-
Figure 6. Self-inflicted mechanical damage in SLO-perforated cells. (A–C) The SLO-perforated protrusions of SH-SY5Y or HEK 293 cells are
wrenched apart by mechanical forces. (A) The global translocation of annexin A1-YFP manifests cell lysis. (B,C) The cytoplasmic localization of
annexin A1-YFP within the cell body is evidence of successful resealing of the plasmalemma. The arrow in (B) points at the resealed base of the
destroyed protrusion. The asterisks in (B,C) denote regions of clear demarcation between permeabilized (plasmalemmal localization of annexin A1-
YFP) and non-permeabilized (cytoplasmic localization of annexin A1-YFP) cellular compartments. Magnification bars = 5 mm.
doi:10.1371/journal.pone.0089743.g006
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ties of the membrane lipid bilayer [43]. Thus, lateral redistribution
of membrane constituents, brought about by the formation of a
toxin pore, might be sufficient to induce nanosized membrane
buds, which elongate into nanotubes and are pinched off from the
membrane to become micro(nano)vesicles [43]. Since, the
formation of nanotubes and their vesiculation/detachment from
the mother vesicles have been documented in artificial giant
phospholipid vesicles [44], these processes might occur spontane-
ously after destabilization of the lipid bilayer by the toxin-pore
formation and presumably require no input from other cellular
constituents.
We show that both microvesicle shedding and lysosomal repair,
which are triggered by the same mechanism (pore-induced
elevation in [Ca2+]i), are similarly affected by the flexibility of
the plasmalemmal lipid bilayer. Thus identical basic mechanisms
apply for both modes of pore elimination; the differences transpire
in more subtle details, and lead to wide-ranging consequences.
Different tasks performed by the two modes of plasmalemmal
repair are, most likely, defined by their physical carriers (proteins
versus organelles) and dependent on (i) intrinsic properties of a cell
(e.g. capability to induce secondary, self-inflicted mechanical
damage), (ii) morphology of a cell and (iii) the repair-induced
changes in cellular homeostasis.
Whereas spatially well-confined toxin lesions can be swiftly
eliminated with minimal detrimental consequences for a cell, an
extensive formation of toxin-pores is often accompanied by
massive mechanical damage. Our data suggest that annexins are
best positioned for the instant repair of individual membrane
lesions via microvesicle shedding, whereas lysosomal fusion is
indispensable for the repair of concomitant mechanical injuries.
Whereas the fusion of bulky lysosomes is restricted to the
plasmalemma of the cell body, the shedding of microvesicles,
which is effected by the relatively mobile proteins of the annexin
family can operate also at the cellular periphery. Additionally,
lysosomal repair of toxin-induced lesions, which are difficult to
access, might be achieved by their conversion into mechanical
ones: the total destruction of the pore-bearing, lysosome-free
protrusions results in the elimination of the toxin-pore by its
release into the extracellular milieu. Simultaneously, a mechan-
ically-inflicted lesion is created in the vicinity of the lysosome-rich
cell body where lysosomes are available for plasmalemmal repair.
Thus, when microvesicle shedding fails to eliminate SLO-pores at
the cellular periphery, a cell enters a ‘‘lizard tail’’ mode of action:
in order to avoid its total destruction, it sacrifices the damaged
peripheral regions. A similar function can be ascribed to
plasmalemmal blebbing [21]. Both blebbing and the self-inflicted
destruction of perforated peripheral components are prompted by
actin-myosin contraction. The role of myosin-driven contraction
in plasmalemmal repair is emphasized by the inability to repair
injuries, in which myosin is inhibited by blebbistatin [21].
The need for repair at two different levels, involving microves-
icle shedding and lysosomal fusion might be also defined by
additional hazards, which occur after the successful resealing of
plasmalemmal lesions. During the repair of extensive damage, cells
experience a prolonged and excessive elevation in [Ca2+]i. Ca
2+ is
a critical second messenger, which is involved in the regulation of a
multitude of cellular processes which necessitates tight control of
its intracellular concentration [45]. The uncontrolled elevation in
[Ca2+]i during plasmalemmal repair might lead to a homeostatic
Figure 7. SLO-perforation inflicts mechanical damage and
triggers lysosomal fusion. (A) HEK 293 cells do not adhere
extensively to the substratum at the cellular periphery while SH-SY5Y
cells are firmly attached by multiple protrusions. Magnification
bars = 2 mm. (B) Inhibition of myosin contraction does not protect
from SLO induced lysis. (C) Lysosomal exocytosis (b-hexosaminidase
release) after SLO-injury is more pronounced in SH-SY5Y cells compared
to HEK 293 cells. (D) Vacuolin-1 does not increase the SLO-induced lysis
in HEK 293 cells. In contrast, Vacuolin-1-treated SH-SY5Y cells are more
prone to the SLO-induced lysis. *p,0.01.
doi:10.1371/journal.pone.0089743.g007
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imbalance, hyper- or de-activation of vital cellular signalling
pathways and irreversible changes in their gene expression pattern
[18,46,47]. Thus, the effective repair after an extensive injury
might lead to even more disastrous long term consequences than
the lysis of a damaged cell.
Therefore, perforated cells are confronted with three tasks: their
lysis must be prevented; repaired cells, which were extensively
damaged, must be eliminated; and slightly damaged cells must be
re-vitalized. During repair by microvesicle shedding, the toxin
pore is immediately quarantined by the annexins; the pore is
expelled into the extracellular milieu with minimal detrimental
consequences allowing the cell to return to its normal state of
function. In contrast, lysosome-plasmalemmal fusion is accompa-
nied by major biochemical and structural changes within the
Figure 8. Microvesicle shedding is responsible for the initial elimination of toxin pores whereas lysosomal repair mends secondary,
self-inflicted mechanical injuries. (A) Individual experiments in which SH-SY5Y cells either repaired efficiently (low damage; 72 cells, 3
independent experiments) or suffered from extensive plasmalemmal damage (high damage; 66 cells, 3 independent experiments) were analyzed for:
(B) amount of microvesicles released per cell, (C) percentage of cells that suffered from secondary, self-inflicted mechanical damage (100%= total
number of cells in each individual experiment), (D) percentage of cells that recovered after self-inflicted mechanical damage (100%=number of
mechanically-damaged cells in each individual experiment), (E) contribution of lysosomal repair to total repair (100%= total number of repaired cells
in each individual experiment). **p,0.001, *p,0.01.
doi:10.1371/journal.pone.0089743.g008
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plasmalemma. An exposure of the sphingomyelin-rich outer leaflet
of the plasmalemmal lipid bilayer to the lysosomal acid
sphingomyelinase leads to the formation of the pro-apoptotic
sphingolipid ceramide [11]. The pro-apoptotic action of ceramide
is greatly potentiated by its self-association within plasmalemmal
ceramide platforms [48,49]. The formation of ceramide platforms
in cells, which were heavily damaged by SLO, has been reported
earlier [12] and the inward plasmalemmal budding caused by their
assembly following lysosome-plasmalemmal fusion is a prerequisite
for the endocytosis of pore-bearing membranes [11]. Whereas
multiple pathways are involved in ceramide-induced apoptosis, the
very formation of ceramide platforms is presumably sufficient to
trigger apoptosis. The inward budding and internalization of
ceramide platforms is followed by their fusion with mitochondria
and permeabilization of the mitochondrial outer membrane
[50,51]. Thus, plasmalemmal repair by lysosomal fusion appears
to be perfectly suited for the apoptotic elimination of repaired cells
that suffer from a surfeit of Ca2+.
Our data suggest that both microvesicle shedding and lysosomal
fusion are employed by toxin-damaged cells to enable an intrinsic
resealing of a lipid bilayer - a fundamental process, which is
facilitated by the destabilization of the cortical cytoskeleton and is
mediated by the spontaneous reorganization of plasmalemmal
lipid constituents into their thermodynamically most favorable
state. Whereas the pinpoint action of microvesicle shedding is
optimal for the early elimination of toxin pores allowing the
survival of damaged cells, the lysosomal fusion is best suited for the
repair of extended secondary self-inflicted mechanical injuries.
Supporting Information
Video S1 Video S1 shows the release of microvesicles by
SLO-permeabilized HEK 293 cells. HEK 293 cells, trans-
fected with annexin A1-YFP, were challenged with SLO/DTT.
The movie (time-lapse mode) spans 2643 s.
(MOV)
Video S2 Video S2 shows that non-permeabilized HEK
293 cells do not release microvesicles. HEK 293 cells,
transfected with annexin A1-YFP, were challenged with DTT
alone. The movie (time-lapse mode) spans 2643 s.
(MOV)
Video S3 Video S3 shows budding and release of an
annexin A1-enriched microvesicle by a SLO-treated HEK
293 cell. HEK 293 cells, transfected with annexin A1-YFP, were
challenged with SLO. Partial view of one cell. The movie (time-
lapse mode) spans 157 s.
(MOV)
Video S4 Video S4 shows the formation of an annexin
A1-enriched plasmalemmal protrusion, followed by
release of microvesicles in a SLO-treated HEK 293 cell.
HEK 293 cells, transfected with annexin A1-YFP, were challenged
with SLO. The movie (time-lapse mode) spans 403 s.
(MOV)
Video S5 Video S5 shows a plasmalemmal transloca-
tion-cytoplasmic back-translocation of annexin A1 local-
ized within a neurite of a SLO-treated SH-SY5Y cell. SH-
SY5Y cells, transfected with annexin A1-YFP, were challenged
with SLO. The movie (time-lapse mode) spans 124 s.
(MOV)
Video S6 Video S6 shows a plasmalemmal transloca-
tion-cytoplasmic back-translocation of annexin A1 local-
ized within a bleb of a SLO-treated HEK 293 cell. Hek
293cells, transfected with annexin A1-YFP, were challenged with
SLO. The movie (time-lapse mode) spans 201 s.
(MOV)
Video S7 Video S7 shows a plasmalemmal translocation
of annexin A1 localized within a protrusion of a SLO-
treated SH-SY5Y cell, followed by contraction and
rupture of the protrusion. Note the plasmalemmal localiza-
tion of annexin A1 within the cell body of the damaged cell. SH-
SY5Y cells, transfected with annexin A1-YFP, were challenged
with SLO. The movie (time-lapse mode) spans 258 s.
(MOV)
Video S8 Video S8 shows a plasmalemmal translocation
of annexin A1 localized initially within a protrusion of a
SLO-treated HEK 293 cell, followed by contraction and
rupture of the protrusion. Note the cytoplasmic localization
of annexin A1 within the cell body of the damaged cell. HEK 293
cells, transfected with annexin A1-YFP, were challenged with
SLO. The movie (time-lapse mode) spans 844 s.
(MOV)
Video S9 Video S9 shows a plasmalemmal translocation
of annexin A1 localized within protrusions of a SLO-
treated SH-SY5Y cell, followed by contraction and
rupture of the protrusions. Note the cytoplasmic localization
of annexin A1 within the cell body of the damaged cell. SH-SY5Y
cells, transfected with annexin A1-YFP, were challenged with
SLO. The movie (time-lapse mode) spans 415 s
(MOV)
Video S10 Video S10 shows that SLO-induced damage
does not induce significant contraction of HEK 293 cells.
HEK 293 cells, transfected with annexin A1-YFP, were challenged
with SLO. The movie (time-lapse mode) spans 938 s
(MOV)
Video S11 Video S11 shows that SLO-induced damage is
accompanied by massive contraction of extended pro-
trusions of SH-SY5Y cells. SH-SY5Y cells, transfected with
annexin A1-YFP, were challenged with SLO. The movie (time-
lapse mode) spans 938 s
(MOV)
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